Vitamin E in neurodegenerative disorders: Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 1031, Issue , 2004, Pages 249-262

  Kontush, Anatol ^a   Schekatolina, Svetlana ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b ODESSA NATIONAL ACADEMY OF FOOD TECHNOLOGIES   (Ukraine)

Author keywords

Alzheimer's disease; Amyloid ; Brain; Cerebrospinal fluid; Computer modeling; Free radicals; Lipoproteins; Oxidative stress; Transition metals; Vitamin E; tocopherol

Indexed keywords

4 HYDROXYNONENAL; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ASCORBIC ACID; CHOLINESTERASE INHIBITOR; COPPER; DONEPEZIL; FREE RADICAL; IRON; ISOPROSTANE DERIVATIVE; LIPID; LIPOPROTEIN; PLACEBO; SELEGILINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; URATE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; BRAIN LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL TRIAL; COMPUTER MODEL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOUBLE BLIND PROCEDURE; HUMAN; INCIDENCE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NITRATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SYSTEMATIC REVIEW; TRANSGENIC MOUSE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

MUS MUSCULUS;

EID: 14944382913     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1331.025     Document Type: Conference Paper

References (58)

1. PRATICO, D. & N. DELANTY. 2000. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am. J. Med. 109: 577-585.
2. BUTTERFIELD, D.A. 2002. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain: a review. Free Radic. Res. 36: 1307-1313.
3. ARLT, S., U. BEISIEGEL & A. KONTUSH. 2002. Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease. Curr. Opin. Lipidol. 13: 289-294.
4. PRATICO, D., M.Y.L. V, J.Q. TROJANOWSKI, et al. 1998. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 12: 1777-1783.
5. LOVELL, M.A., C. XIE, W.R. MARKESBERY. 2001. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22: 187-194.
6. SMITH, M.A., C.A. ROTTKAMP, A. NUNOMURA, et al. 2000. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 1502: 139-144.
7. MARKESBERY, W.R. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23: 134-147.
8. KONTUSH, A., C. BERNDT, W. WEBER, et al. 2001. Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic. Biol. Med. 30: 119-128.
9. Zou, K., J.S. GONG, K. YANAGISAWA, et al. 2002. A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J. Neurosci. 22: 4833-4841.
10. KONTUSH, A. 2001. Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease. Free Radic. Biol. Med. 31: 1120-1131.
11. ATWOOD, C.S., M.E. OBRENOVICH, T. LIU, et al. 2003. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res. Brain Res. Rev. 43: 1-16.
12. TOHGI, H., T. ABE, M. NAKANISHI, et al. 1994. Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia. Neurosci. Lett. 174: 73-76.
13. JIMENEZ-JIMENEZ, F.J., F. DE BUSTOS, J.A. MOLINA, et al. 1997. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease. J. Neural Transm. 104: 703-710.
14. SCHIPPLING, S., A. KONTUSH, S. ARLT, et al. 2000. Increased lipoprotein oxidation in Alzheimer's disease. Free Radic. Biol. Med. 28: 351-360.
15. MONTINE, T.J., M.F. BEAL, M.E. CUDKOWICZ, et al. 1999. Increased CSF F2-isoprostane concentration in probable AD. Neurology 52: 562-565.
16. PRATICO, D. & S. SUNG. 2004. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J. Alzheimers Dis. 6: 171-175.
17. WILLIAMSON, K.S., S.P. GABBITA, S. Mou, et al. 2002. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 6: 221-227.
18. QUINN, J., J. SUH, M.M. MOORE, et al. 2003. Antioxidants in Alzheimer's disease: vitamin C delivery to a demanding brain. J. Alzheimers Dis. 5: 309-313.
19. LONNROT, K., T. METSA KETELA, G. MOLNAR, et al. 1996. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Free Radic. Biol. Med. 21: 211-217.
20. KONTUSH, A., U. MANN, S. ARLT, et al. 2001. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic. Biol. Med. 31: 345-354.
21. SKOUMALOVA, A., J. ROFINA, Z. SCHWIPPELOVA, et al. 2003. The role of free radicals in canine counterpart of senile dementia of the Alzheimer type. Exp. Gerontol. 38: 711-719.
22. METCALFE, T., D.M. BOWEN & D.P. MULLER. 1989. Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls. Neurochem. Res. 14: 1209-1212.
23. RINALDI, P., M.C. POLIDORI, A. METASTASIO, et al. 2003. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol. Aging 24: 915-919.
24. MECOCCI, P., M.C. POLIDORI, A. CHERUBINI, et al. 2002. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch. Neurol. 59: 794-798.
25. POLIDORI, M.C. & P. MECOCCI. 2002. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J. Alzheimers Dis. 4: 517-522.
26. BOURDEL-MARCHASSON, I., M.C. DELMAS-BEAUVIEUX, E. PEUCHANT, et al. 2001. Anti-oxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 30: 235-241.
27. FOY, C.J., A.P. PASSMORE, M.D. VAHIDASSR, et al. 1999. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. Q.J.M. 92: 39-45.
28. SINCLAIR, A.J., A.J. BAYER, J. JOHNSTON, et al. 1998. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. Int. J. Geriatr. Psychiatry 13: 840-845.
29. ZAMAN, Z., S. ROCHE, P. FIELDEN, et al. 1992. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 21: 91-94.
30. JEANDEL, C., M.B. NICOLAS, F. DUBOIS, et al. 1989. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35: 275-282.
31. CHARLTON, K.E., T.L. RABINOWITZ, L.N. GEFFEN, et al. 2004. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J. Nutr. Health Aging 8: 99-107.
32. RYGLEWICZ, D., M. RODO, P.K. KUNICKI, et al. 2002. Plasma antioxidant activity and vascular dementia. J. Neurol. Sci. 203-204: 195-197.
33. FERNANDES, M.A., M.T. PROENCA, A.J. NOGUEIRA, et al. 1999. Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients. Int. J. Mol. Med. 4: 179-186.
34. RIVIERE, S., I. BIRLOUEZ-ARAGON, F. NOURHASHEMI, et al. 1998. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int. J. Geriatr. Psychiatry 13: 749-754.
35. AHLSKOG, J.E., R.J. UITTI, P.A. Low, et al. 1995. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease. Mov. Disord. 10: 566-573.
36. SANO, M., C. ERNESTO, R.G. THOMAS, et al. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease: The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336: 1216-1222.
37. ONOFRJ, M., A. THOMAS, A.L. LUCIANO, et al. 2002. Donepezil versus vitamin E in Alzheimer's disease. Part 2. Mild versus moderate-severe Alzheimer's disease. Clin. Neuropharmacol. 25: 207-215.
38. ZANDI, P.P., J.C. ANTHONY, A.S. KHACHATURIAN, et al. 2004. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County study. Arch. Neurol. 61: 82-88.
39. STOCKER, R. 1994. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr. Opin. Lipidol. 5: 422-433.
40. MORRIS, M.C., D.A. EVANS, J.L. BIENIAS, et al. 2002. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J. Am. Med. Assoc. 287: 3230-3237.
41. ENGELHART, M.J., M.I. GEERLINGS, A. RUITENBERG, et al. 2002. Dietary intake of antioxidants and risk of Alzheimer disease. J. Am. Med. Assoc. 287: 3223-3229.
42. MORRIS, M.C., L.A. BECKETT, P.A. SCHERR, et al. 1998. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis. Assoc. Disord. 12: 121-126.
43. LUCHSINGER, J.A., M.X. TANG, S. SHEA, et al. 2003. Antioxidant vitamin intake and risk of Alzheimer disease. Arch. Neurol. 60: 203-208.
44. MASAKI, K.H., K.G. LOSONCZY, G. IZMIRLIAN, et al. 2000. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 54: 1265-1272.
45. VATASSERY, G.T., T. BAUER & M. DYSKEN. 1999. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am. J. Clin. Nutr. 70: 793-801.
46. MCINTOSH, L.J., M.A. TRUSH & J.C. TRONCOSO. 1997. Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes. Free Radic. Biol. Med. 23: 183-190.
47. BASSETT, C.N., K.S. MONTINE, M.D. NEELY, et al. 2000. Cerebrospinal fluid lipoproteins in Alzheimer's disease. Microsc. Res. Tech. 50: 282-286.
48. BURNS, M.P., W.J. NOBLE, V. OLM, et al. 2003. Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques. Brain Res. Mol. Brain Res. 110: 119-125.
49. BASSETT, C.N., M.D. NEELY, K.R. SIDELL, et al. 1999. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids 34: 1273-1280.
50. ARLT, S., B. FINCKH, U. BEISIEGEL, et al. 2000. Time-course of oxidation of lipids in human Cerebrospinal fluid in vitro. Free Radic. Res. 32: 103-114.
51. SUNG, S., Y. YAO, K. URYU, et al. 2004. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model ]of Alzheimer's disease. FASEB J. 18: 323-325. [e-pub 2003, print Dec. 2004.
52. NEUZIL, J., C. WEBER & A. KONTUSH. 2001. The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease. Atherosclerosis 157: 257-283.
53. UPSTON, J.M., L. KRITHARIDES & R. STOCKER. 2003. The role of vitamin E in atherosclerosis. Prog. Lipid Res. 42: 405-422.
54. BOWRY, V.W. & R. STOCKER. 1993. Tocopherol-mediated peroxidation: the prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc. 115: 6029-6044.
55. KONTUSH, A., B. FINCKH, B. KARTEN, et al. 1996. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low-density lipoprotein. J. Lipid Res. 37: 1436-1448.
56. KONTUSH, A. 2001. Alzheimer's amyloid-beta as a preventive antioxidant for brain lipoproteins. Cell. Mol. Neurobiol. 21: 299-315.
57. EVANS, P.J., A. BOMFORD & B. HALLIWELL. 1989. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum: ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease. Free Radic. Res. Commun. 7: 55-62.
58. DURKEN, M., P. NIELSEN, S. KNOBEL, et al. 1997. Nontransferrin-bound iron in serum of patients receiving bone marrow transplants. Free Radic. Biol. Med. 22: 1159-1163.